We believe our results show that when counselling women on their risks of breast and ovarian cancer if they carry a family BRCA1/2 mutation the risks should reflect the context of cancer in their family and not just an average risk from possibly over-corrected penetrance estimates from population studies. Here, BRCA1 is linked to ovarian carcinoma.